KEYTRUDA (Pembrolizumab) for Injection

What is Keytruda (Pembrolizumab)
Keytruda is a medicine that may treat your melanoma by working with your immune system. Keytruda can cause your immune system to attack normal organs and tissues in many areas of your body and can affect the way they work.

KEYTRUDA

Drug Manufacturer / Marketeer :

M/s Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc


Available as:

50MG Injection.

Indications:

  • Keytruda is a human programmed death receptor-1(PD-1)- blocking antibody indicated for the treatment of patients with unresectable or metastatic melanoma and disease progression following ipilimumab and if, BRAF V600 mutation positive, a BRAF inhibitor.
  • This indication is approved under accelerated approval based on tumor response rate and durability of response. An improvement in survival or disease related symptoms has not yet been established.

Treatment:
For treatment related information, please consult your treating Physician.

How supplied:
Keytruda is supplied in a carton containing one 50 mg single-use vial

Storage and handling:
Store vials under refrigeration at 2° to 8°, do not freeze or shake

How do we source the Drug?
SMIQ Pharma will assist in sourcing the drug through its efficient network, across the globe, and ensure the delivery is prompt. However, a valid prescription from the treating Oncologist is mandatory, with all relevant documents associated with its procurement is also essential.

Company that Manufactures/ Markets:
M/s Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc

Assistance Cell in India:
For ONCOLOGY DRUG: KEYTRUDA (Pembrolizumab) for Injection 50MG price.

Contact us @ +91 7678048225 or by email  info@smiqpharma.com.